Analystreport

Coherus Oncology (NASDAQ:CHRS) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.

Coherus Oncology, Inc.  (CHRS) 
Last coherus oncology, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com